[
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-1",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#definitiongeneral268861",
    "clean_content": "Definition / general\n\n* Uncommon morphologic variant of pancreatic well differentiated neuroendocrine tumor; associated with von Hippel-Lindau syndrome (VHL) and multiple endocrine neoplasia type I (MEN I) syndrome"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-2",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#essentialfeatures268862",
    "clean_content": "Essential features\n\n* Clear, vacuolated cytoplasm due to accumulation of lipid, glycogen or mucin* Characteristic salt and pepper nuclear chromatin features* Can be easily misdiagnosed due to morphologic similarities with primary and metastatic tumors of the pancreas"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-3",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Terminology",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#terminology268863",
    "clean_content": "Terminology\n\n* Also known as lipid rich variant"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-4",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "ICD coding",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#icdcoding268864",
    "clean_content": "ICD coding\n\n* ICD-10: [C25.4](https://www.icd10data.com/ICD10CM/Codes/C00-D49/C15-C26/C25-/C25.4) - malignant neoplasm of endocrine pancreas"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-5",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#epidemiology268865",
    "clean_content": "Epidemiology\n\n* Adults ages 40 - 60* No sex predilection* Syndromic patients may present at an earlier age ([Pathol Res Pract 2016;212:747](27161305))"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-6",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Sites",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#sites268866",
    "clean_content": "Sites\n\n* Most commonly in the head of the pancreas"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-7",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Pathophysiology",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#pathophysiology268867",
    "clean_content": "Pathophysiology\n\n* In VHL, the disease results from deletions or mutations in the *VHL* tumor suppressor gene on chromosome 3p25.5 ([Mod Pathol 2011;24:S66](21455203))* Mutations in *MEN1* on chromosome 11q result in loss of function of tumor suppressor protein menin ([Mod Pathol 2011;24:S66](21455203))* Sporadic tumors consistently result from allelic loss of chromosome 11q"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-8",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Clinical features",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#clinicalfeatures268868",
    "clean_content": "Clinical features\n\n* Patients with VHL or MEN I may be screened following clinical suspicion* Patients may present for evaluation of abdominal symptoms or abnormal laboratory results* Some cases may be found incidentally on imaging ([Mod Pathol 2011;24:S66](21455203))* Pancreatic neuroendocrine tumors in VHL or MEN I are typically nonfunctional ([Arch Pathol Lab Med 2006;130:963](16831051))"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-9",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#diagnosis268869",
    "clean_content": "Diagnosis\n\n* Imaging may identify a suspicious mass* Definitive diagnosis is made following endoscopic biopsy or surgical resection"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-10",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Radiology description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#radiologydescription268870",
    "clean_content": "Radiology description\n\n* Hyperintense, enhancing mass, well circumscribed with sharp borders on computed tomography ([Radiographics 2010;30:1445](21071369))"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-11",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Prognostic factors",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#prognosticfactors268871",
    "clean_content": "Prognostic factors\n\n* Worse prognosis with high Ki67 proliferative index, tumor size > 2 cm, nonfunctioning tumors, tumor necrosis and poor response to chemotherapy ([J Hepatobiliary Pancreat Sci 2015;22:586](25641911), [Mod Pathol 2011;24:S66](21455203))"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-12",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#casereports268872",
    "clean_content": "Case reports\n\n* 29 year old man with liver and pancreatic lesions ([Diagn Cytopathol 2009;37:365](19217049))* 32 year old woman with abdominal pain and a pancreatic mass ([Cytojournal 2016;13:7](27081395))* 47 year old woman presenting with a mass in the pancreatic tail ([Neuro Endocrinol Lett 2017;38:83](28650600))* 60 year old woman with pancreatic cysts and octreotide avid lesions ([Virchows Arch 2013;463:593](23913169))* 64 year old man with a nodule in the head of the pancreas ([Cytopathology 2013;24:197](22489965))"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-13",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Treatment",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#treatment268873",
    "clean_content": "Treatment\n\n* Surgical resection and chemotherapy ([Mod Pathol 2011;24:S66](21455203))"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-14",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Gross description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#grossdescription268874",
    "clean_content": "Gross description\n\n* Most often solid, solitary, homogenous, tan to yellow ([Am J Surg Pathol 2001;25:602](11342771))* If extensive fibrosis present, may be gray and firm ([J Hepatobiliary Pancreat Sci 2015;22:586](25641911))* Hereditary syndromes may present with multiple tumors* Rarely a cystic component can be seen ([Neuro Endocrinol Lett 2017;38:83](28650600))"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-15",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Microscopic (histologic) description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#microscopichistologicdescription268875",
    "clean_content": "Microscopic (histologic) description\n\n* Solitary, well circumscribed* Widely variable architectural patterns: nested, trabecular, glandular, ribbon-like, tubuloacinar, mixed patterns are common; however, there is usually a dominant pattern ([Arch Pathol Lab Med 2006;130:963](16831051))* Small / medium round, polygonal cells with clear, vacuolated cytoplasm due to lipid accumulation* Central nucleus with characteristic salt and pepper chromatin pattern and inconspicuous nucleoli ([Arch Pathol Lab Med 2009;133:350](19260741))"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-16",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#microscopichistologicimages268876",
    "clean_content": "Microscopic (histologic) images\n\n*Contributed by Aatur Singhi, M.D., Ph.D.*  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasclearcellendocrineSinghi01new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasclearcellendocrineSinghi01new.jpg)\n\nNests of tumor cells\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasclearcellendocrineSinghi02new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasclearcellendocrineSinghi02new.jpg)\n\nClear, vacuolated cytoplasm\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasclearcellendocrineSinghi03new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasclearcellendocrineSinghi03new.jpg)\n\nSalt and pepper chromatin\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreasclearcellendocrineSinghi04new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasclearcellendocrineSinghi04new.jpg)\n\nSynaptophysin positivity"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-17",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Cytology description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#cytologydescription268877",
    "clean_content": "Cytology description\n\n* Isolated or small clusters of round monomorphic tumor cells ([Cytopathology 2013;24:197](22489965))* Numerous small cytoplasmic vacuoles imparting a foamy appearance* Eccentric nuclei with fine nuclear chromatin, without prominent nucleoli ([J Hepatobiliary Pancreat Sci 2015;22:586](25641911))"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-18",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Cytology images",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#cytologyimages268878",
    "clean_content": "Cytology images\n\n*Image hosted on other servers:*  \n\n[![Missing Image](https://www.pathologyoutlines.com/thumb/pancreasclearcellendocrineotherimg06.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812879/figure/F3/)\n\nPapanicolaou stain of FNA"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-19",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Positive stains",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#positivestains268879",
    "clean_content": "Positive stains\n\n* [Synaptophysin](https://www.pathologyoutlines.com/topic/stainssynaptophysin.html), [chromogranin A](https://www.pathologyoutlines.com/topic/stainschromogranin.html), [CD56](https://www.pathologyoutlines.com/topic/cdmarkerscd56.html), [AE1 / AE3](https://www.pathologyoutlines.com/topic/stainsae1ae3.html), [PAX8](https://www.pathologyoutlines.com/topic/stainspax8.html) ([Laboratory Medicine 2009;40:417](https://doi.org/10.1309/LM5MY3OCDWWKS6NM), [Cytopathology 2013;24:197](22489965), [Virchows Arch 2013;463:593](23913169), [J Hepatobiliary Pancreat Sci 2015;22:586](25641911))"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-20",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Negative stains",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#negativestains268880",
    "clean_content": "Negative stains\n\n* [CK7](https://www.pathologyoutlines.com/topic/stainsck7.html), [CK20](https://www.pathologyoutlines.com/topic/stainsck20.html), [MelanA](https://www.pathologyoutlines.com/topic/stainsmart1.html), [CAIX](https://www.pathologyoutlines.com/topic/stainscarbonicanhydraseix.html), [HMB45](https://www.pathologyoutlines.com/topic/stainshmb45.html) ([Mod Pathol 2008;21:1075](18536653), [Cytopathology 2013;24:197](22489965), [Arch Pathol Lab Med 2010;134:1080](20586642), [J Hepatobiliary Pancreat Sci 2015;22:586](25641911))"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-21",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Electron microscopy description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#electronmicroscopydescription268881",
    "clean_content": "Electron microscopy description\n\n* Variably sized cytoplasmic lipid globules and dense neurosecretory granules ([Arch Pathol Lab Med 2009;133:350](19260741))"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-22",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Molecular / cytogenetics description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#molecularcytogeneticsdescription268882",
    "clean_content": "Molecular / cytogenetics description\n\n* Von Hippel-Lindau disease\n  + Autosomal dominant mutation in *VHL* tumor suppressor gene on chromosome 3p25.5 ([Arch Pathol Lab Med 2010;134:1080](20586642))* Multiple endocrine neoplasia type I\n    + Autosomal dominant germline mutation in *MEN1* tumor suppressor gene on chromosome 11q13* Sporadic tumors may arise from chromosomal alterations, epigenetic changes or functional genomic alterations"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-23",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Videos",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#videos268883",
    "clean_content": "Videos\n\nPancreatic neuroendocrine neoplasms: overview"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-24",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Sample pathology report",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#samplepathologyreport268884",
    "clean_content": "Sample pathology report\n\n* Pancreas and duodenum, Whipple procedure:\n  + Clear cell pancreatic neuroendocrine tumor, WHO grade 1 (see synoptic report and comment)+ Comment: The patient's clinical history of von Hippel-Lindau syndrome is noted. The clear cell variant of pancreatic neuroendocrine tumor is more common in this setting. Immunohistochemical stains for synaptophysin and chromogranin are positive and the Ki67 index is approximately 2.0%."
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-25",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Differential diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#differentialdiagnosis268885",
    "clean_content": "Differential diagnosis\n\n* **Metastatic**:\n  + [Renal cell carcinoma, clear cell type](https://www.pathologyoutlines.com/topic/kidneytumormalignantrccclear.html):\n    - Positive for [AE1/AE3](https://www.pathologyoutlines.com/topic/stainsae1ae3.html), [CD10](https://www.pathologyoutlines.com/topic/cdmarkerscd10.html), [PAX8](https://www.pathologyoutlines.com/topic/stainspax8.html), [CAIX](https://www.pathologyoutlines.com/topic/stainscarbonicanhydraseix.html)- Negative for [neuroendocrine markers](https://www.pathologyoutlines.com/topic/pancreaspen.html) ([Arch Pathol Lab Med 2010;134:1080](20586642))* **Primary**:\n    + [Ductal adenocarcinoma with clear cell features](https://www.pathologyoutlines.com/topic/pancreasductal.html):\n      - Positive for [AE1 / AE3](https://www.pathologyoutlines.com/topic/stainsae1ae3.html)- Negative for [neuroendocrine markers](https://www.pathologyoutlines.com/topic/pancreaspen.html)+ [Serous cystadenoma, solid variant](https://www.pathologyoutlines.com/topic/pancreasserous.html):\n        - Positive for [PAS](https://www.pathologyoutlines.com/topic/stainspas.html), [AE1 / AE3](https://www.pathologyoutlines.com/topic/stainsae1ae3.html), [vimentin](https://www.pathologyoutlines.com/topic/stainsvimentin.html)- Negative for [synaptophysin](https://www.pathologyoutlines.com/topic/stainssynaptophysin.html)+ [Solid pseudopapillary neoplasm, clear cell variant](https://www.pathologyoutlines.com/topic/pancreassolidpseudo.html):\n          - Positive for [beta catenin](https://www.pathologyoutlines.com/topic/stainsbetacatenin.html) (nuclear and cytoplasmic), [CD10](https://www.pathologyoutlines.com/topic/cdmarkerscd10.html), [CD56](https://www.pathologyoutlines.com/topic/cdmarkerscd56.html), [vimentin](https://www.pathologyoutlines.com/topic/stainsvimentin.html)- Variable [neuroendocrine markers](https://www.pathologyoutlines.com/topic/pancreaspen.html)- Loss of [E-cadherin](https://www.pathologyoutlines.com/topic/stainsecadherin.html) ([J Hepatobiliary Pancreat Sci 2015;22:586](25641911))+ **Clear cell sugar tumor / PEComa**:\n            - Positive for [PAS](https://www.pathologyoutlines.com/topic/stainspas.html), [HMB45](https://www.pathologyoutlines.com/topic/stainshmb45.html)* **Peripancreatic region**:\n      + [Adrenocortical tumors](https://www.pathologyoutlines.com/topic/adrenocorticalcarcinoma.html):\n        - Positive for inhibin, [MelanA](https://www.pathologyoutlines.com/topic/stainsmart1.html)- Weak with [AE1 / AE3](https://www.pathologyoutlines.com/topic/stainsae1ae3.html)- Negative for [chromogranin A](https://www.pathologyoutlines.com/topic/stainschromogranin.html) ([J Hepatobiliary Pancreat Sci 2015;22:586](25641911))+ [Clear cell hepatocellular carcinoma](https://www.pathologyoutlines.com/topic/livertumorclearcellHCC.html):\n          - Positive for [Arginase1](https://www.pathologyoutlines.com/topic/stainsarginase1.html), [HepPar1](https://www.pathologyoutlines.com/topic/stainsheppar1.html)- Negative for [neuroendocrine markers](https://www.pathologyoutlines.com/topic/pancreaspen.html)"
  },
  {
    "id": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt-26",
    "source_document": "clear-cell-pancreatic-endocrine-tumor_30429_1750166973.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Additional references",
    "url": "https://www.pathologyoutlines.com/topic/pancreasclearcellendocrine.html#additionalreferences268886",
    "clean_content": "Additional references\n\n* [Am J Surg Pathol 2006;30:194](16434893),\n  [Adv Anat Pathol 2004;11:202](15220823)"
  }
]